Key result
Cutaneous lupus erythematosus is linked to increased ASCVD risk matching SLE and exceeding psoriasis.
Why the study?
Does Cutaneous Lupus Erythematosus increase the risk of Atherosclerotic Cardiovascular Disease compared to SLE or psoriasis?
Cohort
Does Cutaneous Lupus Erythematosus increase the risk of Atherosclerotic Cardiovascular Disease compared to SLE or psoriasis?
Answers are grounded in this paper and cite their sources.
Patients with cutaneous lupus erythematosus have an increased risk of atherosclerotic cardiovascular disease, similar to systemic lupus erythematosus, warranting appropriate screening.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2024) conducted a cohort in Cutaneous Lupus Erythematosus. Cutaneous Lupus Erythematosus vs. Systemic Lupus Erythematosus and Psoriasis was evaluated on Atherosclerotic Cardiovascular Disease (ASCVD). Cutaneous lupus erythematosus was associated with an increased risk for atherosclerotic cardiovascular disease, similar to the risk in systemic lupus erythematosus but higher than in psoriasis.
Synapse has enriched 10 related papers. Consider them for comparative context: